A Patient with Newly Diagnosed Diabetes Presenting with Sino-Orbital Mucormycosis

AACE Clinical Case Reports

Volumn 2, Issue 1, 2016, Pages e41-e45

  Saul, Shira R ^a   Aleksic, Sandra ^b   Magnotti, Michael ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85018788170     PISSN: None     EISSN: 23760605     Source Type: Journal    
DOI: 10.4158/EP14559.CR     Document Type: Article

References (20)

1. Spellberg, B., Edwards, J. Jr, Ibrahim, A., Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18 (2005), 556–569.
2. Roden, M.M., Zaoutis, T.E., Buchanan, W.L., et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41 (2005), 634–653.
3. Bitar, D., Van Cauteren, D., Lanternier, F., et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 15 (2009), 1395–1401.
4. Rees, J.R., Pinner, R.W., Hajjeh, R.A., Brandt, M.E., Reingold, A.L., The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992–1993: results of population-based laboratory active surveillance. Clin Infect Dis 27 (1998), 1138–1147.
5. Torres-Narbona, M., Guinea, J., Martínez-Alarcón, J., Muñoz, P., Gadea, I., Bouza, E., Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol 45 (2007), 2051–2053.
6. Rammaert, B., Lanternier, F., Poirée, S., Kania, R., Lortholary, O., Diabetes and mucormycosis: a complex interplay. Diabetes Metab 38 (2012), 193–204.
7. Chinn, R.Y., Diamond, R.D., Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun 38 (1982), 1123–1129.
8. Ibrahim, A.S., Spellberg, B., Walsh, T.J., Kontoyiannis, D.P., Pathogenesis of mucormycosis. Clin Infect Dis 54:suppl 1 (2012), S16–S22.
9. Peterson, K.L., Wang, M., Canalis, R.F., Abemayor, E., Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 107 (1997), 855–862.
10. Thajeb, P., Thajeb, T., Dai, D., Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. Scand J Infect Dis 36 (2004), 643–648.
11. Fatterpekar, G., Mukherji, S., Arbealez, A., Maheshwari, S., Castillo, M., Fungal diseases of the paranasal sinuses. Semin Ultrasound CT MR 20 (1999), 391–401.
12. Petrikkos, G., Skiada, A., Sambatakou, H., et al. Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 22 (2003), 753–756.
13. Lanternier, F., Dannaoui, E., Morizot, G., et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis 54:suppl 1 (2012), S35–S43.
14. Perlroth, J., Choi, B., Spellberg, B., Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45 (2007), 321–346.
15. Dannaoui, E., Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis. Clin Microbiol Infect 15:suppl 5 (2009), 66–70.
16. Dannaoui, E., Meletiadis, J., Mouton, J.W., Meis, J.F., Verweij, P.E., In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 51 (2003), 45–52.
17. Magnavita, N., Placentino, R.A., Chiusolo, P., Fiorini, A., Laurenti, L., Sica, S., Work-related acute leukemia and mucor mycosis in a boat-builder. Haematologica, 87, 2002, ECR42.
18. Petrikkos, G., Skiada, A., Lortholary, O., Roilides, E., Walsh, T.J., Kontoyiannis, D.P., Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:suppl 1 (2012), S23–S34.
19. Santos Gorjón, P., Blanco Pérez, P., Batuecas Caletrío, A., Muñoz Herrera, A.M., Sánchez González, F., de la Fuente Cañibano, R., Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases [in English, Spanish]. Acta Otorrinolaringol Esp 61 (2010), 48–53.
20. Rammaert, B., Lanternier, F., Zahar, J.R., et al. Healthcare-associated mucormycosis. Clin Infect Dis 54:suppl 1 (2012), S44–S54.